Results: 3

Hipogamaglobulinemia e rituximabe: relato de casos

Arq Asma Alerg Imunol; 7 (3), 2023
Secondary immunodeficiency can result from neoplasms, infections, or immunosuppressive therapy. Rituximab (RTX) is an anti-CD20 antibody that depletes B lymphocytes and can induce symptomatic hypogammaglobulinemia. We report 3 cases of symptomatic hypogammaglobulinemia associated with the use of RTX. In ...

Characteristics of patients with hypersensitivity reactions to chemotherapeutic and biological agents and desensitization behavior

Introduction: Hypersensitivity to chemotherapeutic and biological agents has increased in recent years due to their frequent use. Avoidance has been the first line of defense, leading to decreased treatment efficacy and increased adverse events. Objective: To characterize the sociodemographic and clinica...

Efecto del Rituximab sobre los niveles circulantes de citocinas y quimiocinas producidas o no por los linfocitos B en pacientes con Artritis Reumatoide

Iatreia; 35 (3), 2022
La Artritis Reumatoide (AR) es una enfermedad autoinmune frecuente, caracterizada por inflamación crónica en las articulaciones que puede progresar a la destrucción ósea. Aunque la fisiopatología de la AR no es clara, se ha visto que las células T y las células B desempeñan un importante papel en...